【レポートの概要（一部）】
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
• 2.1 Preface
• 2.2 Preface
• 2.3 Currency conversion rates for US$
PART 03: MARKET LANDSCAPE
• Market ecosystem
• Market characteristics
• Market segmentation analysis
PART 04: MARKET SIZING
• Market definition
• Market sizing 2019
• Market size and forecast 2019-2024
• Market outlook
PART 05: FIVE FORCES ANALYSIS
• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition
PART 06: MARKET SEGMENTATION BY PRODUCT
• Market segmentation by product
• Comparison by product
• Immunosuppressants – Market size and forecast 2019-2024
• Supplementary medications – Market size and forecast 2019-2024
• Market opportunity by product
PART 07: CUSTOMER LANDSCAPE
PART 08: GEOGRAPHIC LANDSCAPE
• Geographic segmentation
• Geographic comparison
• North America – Market size and forecast 2019-2024
• Europe – Market size and forecast 2019-2024
• Asia – Market size and forecast 2019-2024
• ROW – Market size and forecast 2019-2024
• Key leading countries
• Market opportunity
PART 09: DECISION FRAMEWORK
PART 10: DRIVERS AND CHALLENGES
• Market drivers
• Market challenges
PART 11: MARKET TRENDS
• Advent of techniques for organ transplantation
• Increasing strategic alliances
• Growing international collaborations for organ transplantation
PART 12: VENDOR LANDSCAPE
• Overview
• Landscape disruption
• Competitive scenario
PART 13: VENDOR ANALYSIS
• Vendors covered
• Vendor classification
• Market positioning of vendors
• AbbVie Inc.
• Astellas Pharma Inc.
• Cadila Healthcare Ltd.
• F. Hoffmann-La Roche Ltd.
• Mylan NV
• Novartis AG
• Pfizer Inc.
• Sun Pharmaceutical Industries Ltd.
• Teva Pharmaceutical Industries Ltd.
• Veloxis Pharmaceuticals A/S
PART 14: APPENDIX
• Research methodology
• List of abbreviations
• Definition of market positioning of vendors
PART 15: EXPLORE TECHNAVIO
Exhibit 01: Global pharmaceuticals market
Exhibit 02: Segments of global pharmaceuticals market
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Vendor key offerings
Exhibit 06: Market definition – Inclusions and exclusions checklist
Exhibit 07: Market size 2019
Exhibit 08: Global market: Size and forecast 2019-2024 ($ millions)
Exhibit 09: Global market: Year-over-year growth 2020-2024 (%)
Exhibit 10: Five forces analysis 2019
Exhibit 11: Five forces analysis 2024
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition – Five forces 2019
Exhibit 18: Product – Market share 2019-2024 (%)
Exhibit 19: Comparison by product
Exhibit 20: Immunosuppressants – Market size and forecast 2019-2024 ($ millions)
Exhibit 21: Immunosuppressants – Year-over-year growth 2020-2024 (%)
Exhibit 22: Supplementary medications – Market size and forecast 2019-2024 ($ millions)
Exhibit 23: Supplementary medications – Year-over-year growth 2020-2024 (%)
Exhibit 24: Market opportunity by product
Exhibit 25: Customer landscape
Exhibit 26: Market share by geography 2019-2024 (%)
Exhibit 27: Geographic comparison
Exhibit 28: North America – Market size and forecast 2019-2024 ($ millions)
Exhibit 29: North America – Year-over-year growth 2020-2024 (%)
Exhibit 30: Top 3 countries in North America
Exhibit 31: Europe – Market size and forecast 2019-2024 ($ millions)
Exhibit 32: Europe – Year-over-year growth 2020-2024 (%)
Exhibit 33: Top 3 countries in Europe
Exhibit 34: Objectives of European Patients’ Forum
Exhibit 35: Asia – Market size and forecast 2019-2024 ($ millions)
Exhibit 36: Asia – Year-over-year growth 2020-2024 (%)
Exhibit 37: Proportion of geriatric population in Asia 2009 and 2018 (% of total population)
Exhibit 38: Top 3 countries in Asia
Exhibit 39: ROW – Market size and forecast 2019-2024 ($ millions)
Exhibit 40: ROW – Year-over-year growth 2020-2024 (%)
Exhibit 41: Top 3 countries in ROW
Exhibit 42: Key leading countries
Exhibit 43: Market opportunity
Exhibit 44: Benefits of multiple dosage forms of drugs
Exhibit 45: Side effects of immunosuppressants
Exhibit 46: Demand-supply imbalance of organ transplantation 2011-2015
Exhibit 47: Impact of drivers and challenges
Exhibit 48: Vendor landscape
Exhibit 49: Landscape disruption
Exhibit 50: Vendors covered
Exhibit 51: Vendor classification
Exhibit 52: Market positioning of vendors
Exhibit 53: AbbVie Inc. – Vendor overview
Exhibit 54: AbbVie Inc. – Business segments
Exhibit 55: AbbVie Inc. – Organizational developments
Exhibit 56: AbbVie Inc. – Geographic focus
Exhibit 57: AbbVie Inc. – Key offerings
Exhibit 58: AbbVie Inc. – Key customers
Exhibit 59: Astellas Pharma Inc. – Vendor overview
Exhibit 60: Astellas Pharma Inc. – Business segments
Exhibit 61: Astellas Pharma Inc. – Organizational developments
Exhibit 62: Astellas Pharma Inc. – Geographic focus
Exhibit 63: Astellas Pharma Inc. – Key offerings
Exhibit 64: Astellas Pharma Inc. – Key customers
Exhibit 65: Cadila Healthcare Ltd. – Vendor overview
Exhibit 66: Cadila Healthcare Ltd. – Business segments
Exhibit 67: Cadila Healthcare Ltd. – Organizational developments
Exhibit 68: Cadila Healthcare Ltd. – Geographic focus
Exhibit 69: Cadila Healthcare Ltd. – Key offerings
Exhibit 70: Cadila Healthcare Ltd. – Key customers
Exhibit 71: F. Hoffmann-La Roche Ltd. – Vendor overview
Exhibit 72: F. Hoffmann-La Roche Ltd. – Business segments
Exhibit 73: F. Hoffmann-La Roche Ltd. – Organizational developments
Exhibit 74: F. Hoffmann-La Roche Ltd. – Geographic focus
Exhibit 75: F. Hoffmann-La Roche Ltd. – Segment focus
Exhibit 76: F. Hoffmann-La Roche Ltd. – Key offerings
Exhibit 77: F. Hoffmann-La Roche Ltd. – Key customers
Exhibit 78: Mylan NV – Vendor overview
Exhibit 79: Mylan NV – Business segments
Exhibit 80: Mylan NV – Organizational developments
Exhibit 81: Mylan NV – Geographic focus
Exhibit 82: Mylan NV – Segment focus
Exhibit 83: Mylan NV – Key offerings
Exhibit 84: Mylan NV – Key customers
Exhibit 85: Novartis AG – Vendor overview
Exhibit 86: Novartis AG – Business segments
Exhibit 87: Novartis AG – Organizational developments
Exhibit 88: Novartis AG – Geographic focus
Exhibit 89: Novartis AG – Segment focus
Exhibit 90: Novartis AG – Key offerings
Exhibit 91: Novartis AG – Key customers
Exhibit 92: Pfizer Inc. – Vendor overview
Exhibit 93: Pfizer Inc. – Business segments
Exhibit 94: Pfizer Inc. – Organizational developments
Exhibit 95: Pfizer Inc. – Geographic focus
Exhibit 96: Pfizer Inc. – Segment focus
Exhibit 97: Pfizer Inc. – Key offerings
Exhibit 98: Pfizer Inc. – Key customers
Exhibit 99: Sun Pharmaceutical Industries Ltd. – Vendor overview
Exhibit 100: Sun Pharmaceutical Industries Ltd. – Business segments
Exhibit 101: Sun Pharmaceutical Industries Ltd. – Organizational developments
Exhibit 102: Sun Pharmaceutical Industries Ltd. – Geographic focus
Exhibit 103: Sun Pharmaceutical Industries Ltd. – Key offerings
Exhibit 104: Sun Pharmaceutical Industries Ltd. – Key customers
Exhibit 105: Teva Pharmaceutical Industries Ltd. – Vendor overview
Exhibit 106: Teva Pharmaceutical Industries Ltd. – Business segments
Exhibit 107: Teva Pharmaceutical Industries Ltd. – Organizational developments
Exhibit 108: Teva Pharmaceutical Industries Ltd. – Segment focus
Exhibit 109: Teva Pharmaceutical Industries Ltd. – Key offerings
Exhibit 110: Teva Pharmaceutical Industries Ltd. – Key customers
Exhibit 111: Veloxis Pharmaceuticals A/S – Vendor overview
Exhibit 112: Veloxis Pharmaceuticals A/S – Business segments
Exhibit 113: Veloxis Pharmaceuticals A/S – Organizational developments
Exhibit 114: Veloxis Pharmaceuticals A/S – Geographic focus
Exhibit 115: Veloxis Pharmaceuticals A/S – Key offerings
Exhibit 116: Veloxis Pharmaceuticals A/S – Key customers
Exhibit 117: Validation techniques employed for market sizing
Exhibit 118: Definition of market positioning of vendors
【レポート販売概要】
■ タイトル：心臓移植治療薬の世界市場：製品別、地域別■ 英文：Heart Transplantation Therapeutics Market by Product and Geography - Forecast and Analysis 2020-2024
■ 発行日：2019年12月6日
■ 調査会社：Technavio
■ 商品コード：IRTNTR40272
■ 調査対象地域：グローバル
- シアン化水素(HCN)の世界市場予測Hydrogen cyanide 2014 World Market Outlook and Forecast is an absolutely essential resource for anyone looking for detailed information on the mentioned market. Using a wide range of primary and secondary sources, we combined, analyzed and presented all available data about hydrogen cyanide market in the all-in-one report issued in a logical and easily accessible format. In addition to the analyti …
- グルコサミンの世界市場予測・分析2020-2024Global Glucosamine Market: About this market Technavio’s glucosamine market analysis considers sales from both arthritis and other applications. Our study also finds the sales of glucosamine in Asia, Europe, North America, and ROW. In 2018, the arthritis segment had a significant market share, and this trend is expected to continue over the forecast period. Factors such as the rising transition to …
- 癌診断の世界市場：種類別（臨床検査、遺伝子検査、画像診断、内視鏡検査）、用途別（乳房、肺、肝臓、頸部、大腸、皮膚）、セグメント予測The global cancer diagnostics market size is expected to reach USD 249.6 billion by 2026, according to a new report by Grand View Research, Inc., exhibiting a 7.0% during the forecast period. Continual introduction of innovative products, coupled with increasing need for early diagnosis of various diseases, is a prime factor driving the market. In addition, rapid growth of the healthcare and diagn …
- 単純ヘルペス感染症(Herpes Simplex Infections)：治療薬開発パイプライン動向（2015年上半期版）Herpes Simplex Infections - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Herpes Simplex Infections - Pipeline Review, H1 2015’, provides an overview of the Herpes Simplex Infections’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Herpes Simplex Infections, complete with comparative analysis at various stages, therapeutics asse …
- Asacol HD(潰瘍性大腸炎)：市場分析と予測（～2022）Asacol HD (Ulcerative Colitis) - Forecast and Market Analysis to 2022 Summary During the forecast period from 2012-2022, the growth of the UC market will be driven largely by the entry of Johnson & Johnson’s (J&J’s) Simponi and Takeda’s Entyvio, which will lead to an increase in the overall number of patients being treated with biologics in the US, 5EU, Japan, and Canada. Another key event affecti …
- 自動車用冷媒の世界市場2018-2022111 pages, November 2018 About this market In recent years, automotive HVAC systems have gone through numerous developments such as transformation from manual to automatic HVAC and further to multi-zone climate control systems. Automotive HVAC systems are now standard fitments in the passenger car segment, but the commercial vehicle segment was lagging in terms of HVAC penetration. However, this i …
- 光ファイバーの世界市場：通信・ブロードバンド、石油・ガス、ネットワーク、ユーティリティ用途などA fiber optic is a flexible transparent fiber made of extruded glass or plastic which is used in many end-user applications due to its various beneficial properties. The major applications for fiber optics are telecom & broadband, oil & gas, private data network, and utilities industry. The demand in Asia-Pacific is expected to propel by network operators’ efforts to improve connectivity and to ca …
- 世界の電気外科デバイス市場2015The Global Electrosurgical Devices Industry 2015 Market Research Report is a professional and in-depth study on the current state of the Electrosurgical Devices industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Electrosurgical Devices market analysis is provided for the international markets includin …
- 脳損傷(Brain Injury)の治療薬パイプライン動向（2015年上半期版）Brain Injury - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Brain Injury - Pipeline Review, H1 2015’, provides an overview of the Brain Injury’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Brain Injury, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), ro …
- ジオシンセティックスの世界市場：ジオテキスタイル、ジオメンブレン、ジオグリッド、ジオフォーム、ジオネットThe Geosynthetics market size in terms of value is projected to grow at a CAGR of 10.99% between 2014 and 2019 to reach $15,403.7 million by 2019. North America held the largest share in 2013, in terms of value. The Geosynthetics market in North America region is growing fast, mainly due to evolving environmental regulations and standards, for example, The Environmental Protection Agency (EPA) in …
- 世界の自動車エアバッグ布市場2015The Global Automotive Airbag Fabric Industry Report 2015 is a professional and in-depth study on the current state of the Automotive Airbag Fabric industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Automotive Airbag Fabric market analysis is provided for the international markets including development …
- 非在来型ガスの生産方式分析：Analyzing Unconventional Gas Production MethodsThe continued and ever increasing demand for energy resources in developing as well as developed countries is pushing the exploration and production focus of unconventional gas resources. Unconventional gas though had been classified as uneconomic for commercial purposed however these sources have also proved their worth with the development of better techniques to harness them and apply them to c …
- ソーラーポンプの世界市場分析：製品別（DC表面吸引、AC浸水、DC浸水、AC浮動）、用途別（農業、飲料水）、セグメント予測The Global Solar Pumps Market is expected to reach USD 3,639.0 million by 2022, according to a new study by Grand View Research, Inc. Strong shift in trend towards replacing diesel and electric pumps in order to reduce reliance on conventional energy is expected to drive the global solar pumps market. Increasing government support in the form of subsidies and tax benefits particularly in emerging …
- ヘルスケア産業向け3Dプリンターの世界市場：技術、材料、用途別分析About 3D Printing 3D printing is the process of making a three-dimensional model using digital data. It is also known as additive manufacturing, where the object is manufactured (printed) layer by layer using 3D printing material. 3D printing has transformed several industries by enabling customized products manufacturing, thereby preventing the additional cost for complexity and uniqueness. Incre …
- 海底生産及び加工システムの世界市場2016-2026Visiongain assesses that CAPEX on subsea production and processing systems will total $16.36bn in 2016. This includes spending on umbilicals, risers, flowlines, controls, trees, manifolds and tie-ins. Large deepwater subsea projects can take up to ten years from final investment decision to start-up date. Smaller tiebacks can be completed within two years. It is therefore critical that you have yo …
